Abstract
A collateral sensitivity or a very modest cross-resistance to BBR 3464 was found in 2 ovarian cancer cell lines with experimentally induced resistance to cisplatin. Loss of mismatch repair proteins (hMLH1, hPMS2) or overexpression of nucleotide excision repair proteins (ERCC1) was not detrimental for the cellular sensitivity to BBR 3464. Moreover, interesting differences in the kinetics of formation and removal of DNA lesions at the single-gene (N- ras) level were observed between BBR 3464 and CDDP. © 2001 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Behrens BC, Hamilton TC, Masuda H, Grotzinger KR, Whang-Peng J, Louie KG, Knutsen T, McKoy WM, Young RC and Ozols RF (1987) Characterization of a cis-diammine-dichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues. Cancer Res 47: 414–418
Brabec V, Kasparkova J, Vrana O, Novakova O, Cox JW, Qu Y and Farrell N (1999) DNA modifications by a novel bifunctional trinuclear platinum phase I anticancer agent. Biochemistry 38: 6781–6790
Bramson J and Panasci LC (1993) Effect of ERCC1 overexpression on sensitivity of Chinese hamster ovary cells to DNA damaging agents. Cancer Res 53: 3237–3240
Britten RA, Warenius HM, White R, Browning PG and Green JA (1990) Melphalan resistant human ovarian tumour cells are cross- resistant to photons, but not to high LET neutrons. Radiother Oncol 18: 357–363
Dignam JD, Lebovitz RM and Roeder RG (1983) Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11: 1475–1489
Koberle B, Payne J, Grimaldi KA, Hartley JA and Masters JRW (1996) DNA repair in cisplatin-sensitive and resistant human cell lines measured in specific genes by quantitative polymerase chain reaction. Biochem Pharmacol 52: 1729–1734
Manzotti C, Pratesi G, Menta E, Di Domenico R, Cavalletti E, Fiebig HH, Kelland LR, Farrell N, Polizzi D, Supino R, Pezzoni G and Zunino F (2000) BBR 3464: a novel triplatinum complex exhibiting a preclinical profile of antitumor efficacy different from cisplatin. Clin Cancer Res 6: 2626–2634
Murray V, Motyka H, England PR, Wickham G, Lee HH, Denny WA and McFadyen WD (1992) An investigation of the sequence-specific interaction of cis-diamminedichloroplatinum (II) and four analogues, including two acridine-tethered complexes, with DNA inside human cells. Biochemistry 31: 11812–11817
Orlandi L, Colella G, Bearzatto A, Abolafio G, Manzotti C, Daidone MG and Zaffaroni N (2001) Effects of a novel trinuclear platinum complex in cisplatin-sensitive and cisplatin-resistant human ovarian cancer cell lines: interference with cell cycle progression and induction of apoptosis. Eur J Cancer 37: 649–659
Perego P, Caserini C, Gatti L, Carenini N, Romanelli S, Supino R, Colangelo D, Viano I, Leone R, Spinelli S, Pezzoni G, Manzotti C, Farrell N and Zunino F (1999) A novel trinuclear platinum complex overcomes cisplatin resistance in an osteosarcoma cell system. Mol Pharmacol 55: 528–534
Pratesi G, Perego P, Polizzi D, Righetti SC, Supino R, Caserini C, Manzotti C, Giuliani FC, Pezzoni G, Tognella S, Spinelli S, Farrell N and Zunino F (1999) A novel charged trinuclear platinum complex effective against cisplatin-resistant tumours: hypersensitivity of p53-mutant human tumour xenografts. Br J Cancer 80: 1912–1919
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Colella, G., Pennati, M., Bearzatto, A. et al. Activity of a trinuclear platinum complex in human ovarian cancer cell lines sensitive and resistant to cisplatin: cytotoxicity and induction and gene-specific repair of DNA lesions. Br J Cancer 84, 1387–1390 (2001). https://doi.org/10.1054/bjoc.2001.1751
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1054/bjoc.2001.1751
Keywords
This article is cited by
-
Detailed mechanistic study on ligand substitution reactions in dinuclear platinum(II) complexes: effect of alkanediamine linker
Transition Metal Chemistry (2014)
-
Structural consequences of a 3′ → 3′ DNA interstrand cross-link by a trinuclear platinum complex: unique formation of two such cross-links in a 10-mer duplex
JBIC Journal of Biological Inorganic Chemistry (2009)
